Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma

被引:359
作者
Alsayed, Yazan
Ngo, Hai
Runnels, Judith
Leleu, Xavier
Singha, Ujjal K.
Pitsillides, Costas M.
Spencer, Joel A.
Kimlinger, Teresa
Ghobrial, Joanna M. [1 ]
Jia, Xiaoying
Lu, Ganwei
Timm, Michael
Kumar, Ashok
Cote, Daniel
Veilleux, Israel
Hedin, Karen E.
Roodman, G. David
WitZig, Thomas E.
Kung, Andrew L.
Hideshima, Teru
Anderson, Kenneth C.
Lin, Charles P.
Ghobrial, Irene M.
机构
[1] Univ Pittsburgh, Inst Canc, Dept Internal Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed,Adv Microscopy Progam, Boston, MA USA
[5] Mayo Clin, Coll Med, Rochester, MN USA
[6] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[7] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1182/blood-2006-07-035857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which multiple myeloma (MM) cells migrate and home to the bone marrow are not well understood. In this study, we sought to determine the effect of the chemokine SDF-1 (CXCL12) and its receptor CXCR4 on the migration and homing of MM cells. We demonstrated that CXCR4 is differentially expressed at high levels in the peripheral blood and is down-regulated in the bone marrow in response to high levels of SDF-1. SDF-1 induced motility, internalization, and cytoskeletal rearrangement in MM cells evidenced by confocal microscopy. The specific CXCR4 inhibitor AMD3100 and the anti-CXCR4 antibody MAB171 inhibited the migration of MM cells in vitro. CXCR4 knockdown experiments demonstrated that SDF-1-dependent migration was regulated by the PI3K and ERK/MAPK pathways but not by p38 MAPK. In addition, we demonstrated that AMD3100 inhibited the homing of MM cells to the bone marrow niches using in vivo flow cytometry, in vivo confocal microscopy, and whole body bioluminescence imaging. This study, therefore, demonstrates that SDF-1/CXCR4 is a critical regulator of MM homing and that it provides the framework for inhibitors of this pathway to be used in future clinical trials to abrogate MM trafficking.
引用
收藏
页码:2708 / 2717
页数:10
相关论文
共 50 条
  • [1] Chemokines and leukocyte traffic
    Baggiolini, M
    [J]. NATURE, 1998, 392 (6676) : 565 - 568
  • [2] The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
    Balabanian, K
    Lagane, B
    Infantino, S
    Chow, KYC
    Harriague, J
    Moepps, B
    Arenzana-Seisdedos, F
    Thelen, M
    Bachelerie, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35760 - 35766
  • [3] Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1α in acute lymphoblastic leukemia
    Bendall, LJ
    Baraz, R
    Juarez, J
    Shen, W
    Bradstock, KF
    [J]. CANCER RESEARCH, 2005, 65 (08) : 3290 - 3298
  • [4] Billadeau D, 1996, BLOOD, V88, P289
  • [5] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
    Broxmeyer, HE
    Orschell, CM
    Clapp, DW
    Hangoc, G
    Cooper, S
    Plett, PA
    Liles, WC
    Li, XX
    Graham-Evans, B
    Campbell, TB
    Calandra, G
    Bridger, G
    Dale, DC
    Srour, EF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) : 1307 - 1318
  • [6] A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
    Burns, Jennifer M.
    Summers, Bretton C.
    Wang, Yu
    Melikian, Anita
    Berahovich, Rob
    Miao, Zhenhua
    Penfold, Mark E. T.
    Sunshine, Mary Jean
    Littman, Dan R.
    Kuo, Calvin J.
    Wei, Kevin
    McMaster, Brian E.
    Wright, Kim
    Howard, Maureen C.
    Schall, Thomas J.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (09) : 2201 - 2213
  • [7] de Broek IV, 2006, HAEMATOL-HEMATOL J, V91, P200
  • [8] Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100
    De Clercq, E
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 805 - 824
  • [9] RNAI as an experimental and therapeutic tool to study and regulate physiological and disease processes
    Dillon, CP
    Sandy, P
    Nencioni, A
    Kissler, S
    Rubinson, DA
    Van Parijs, L
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2005, 67 : 147 - 173
  • [10] Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells
    Dürig, J
    Rosenthal, C
    Elmaagacli, A
    Heyworth, C
    Halfmeyer, K
    Kasper, C
    Novotny, J
    Dührsen, U
    [J]. LEUKEMIA, 2000, 14 (09) : 1652 - 1660